[ Price : $8.95]
FDA approves an emergency use authorization for InflaRxs Gohibic to treat some hospitalized Covid-19 patients.[ Price : $8.95]
FDA outlines research into potential pharmacodynamic biomarkers for biosimilar development.[ Price : $8.95]
Federal Register notice: FDA establishes a docket to obtain information and comments to help assess whether in-home disposal produ...[ Price : $8.95]
CBER director Peter Marks says Covid-19 vaccine makers will be given advice in June on the next booster vaccine composition for fa...[ Price : $8.95]
Phathom Pharmaceuticals says it will resubmit an NDA for vonoprazan for treating erosive esophagitis, and a post-approval suppleme...[ Price : $8.95]
FDA accepts for review two Pfizer Supplemental NDAs for Braftovi (encorafenib) and Mektovi (binimetinib) and their use in patients...[ Price : $8.95]
FDA clears a BC3 Technologies 510(k) for its SEAL Hemostatic Wound Spray.[ Price : $8.95]
FDA says it is requiring opioid analgesic manufacturers to make prepaid mail-back envelopes available to outpatient pharmacies and...